Your OR could see real benefits from the Food and Drug Administration’s (FDA) proposed unique device identification (UDI) system. But will your systems be ready to capture, record, and retrieve UDI information?
Comments on the FDA’s UDI proposed rule are due by November 7, 2012. The proposal was published July 10, 2012. Congress recently mandated that the final rule be issued no more than 6 months after the comment period closes, or in May 2013. The law calling for a UDI system was passed in 2007.
As proposed, manufacturers would have to apply UDIs to medical device labels and packages, down to the unit level. Some devices, such as implants and reusable surgical instruments, would have the UDI marked directly on them.
The idea is to be able to track a device’s life cycle from the manufacturer until use in a patient, says Jean Sargent, CRST, CMRP, FAHRMM, who has followed the rule closely. A long-time materials management and central sterile manager, she has been a voice for health care providers in efforts to set global product identification standards.
UDIs, which would be both in text and in a scannable format like a barcode, will link to a public database where users can look up standardized information, such as a device’s sterilization and storage requirements (sidebar, p 26).
The implementation timeline is long—7 years for the full rollout. Requirements for the most critical devices (FDA Class 3) would take effect 1 year after the final rule is published.
The rule would apply to manufacturers, not health care facilities. But facilities will need to take steps to make sure they can scan the UDIs and capture them in patients’ electronic health records (EHRs) and other databases.
Become familiar with the rule and consider commenting on areas that affect the OR, Sargent suggests.
ORs and their patients could see important benefits from UDI.
“This is all about patient safety,” says Sargent, who is now with Aspen Healthcare Metrics, a consulting firm.
For one thing, UDIs, once implemented, would make today’s cumbersome recall process more accurate and efficient. When a recall happens, a hospital could query its databases and generate a report showing which patients received the recalled device by model and lot number.
There would also be overall efficiency gains.
“A ton of efficiency issues would happen because of this rule,” notes Dennis Byer, senior director of industry standards for Novation, the health care supply chain company.
Instead of writing or typing a part number, for instance, nurses could scan the UDI into the patient’s EHR or the implant log. They would no longer need to keep a manual log or worry about transcription errors.
They could also use the UDI to link to the national UDI database to access device information, such as whether a device contains latex. That will make it faster and easier to get accurate information that hospitals might struggle to get today, Byer notes.
For the UDI system to work as planned, hospitals and ORs will need the right information systems (IS) and interfaces, even though the rule would not require that.
Manufacturers can’t be successful with implementation “if hospitals can’t carry out their piece of this,” Sargent says. (Suggested questions for OR IS vendors are in the sidebar.)
If you’re considering adding a barcode scanning in the OR, be sure to select a system with camera-based scanners that can read both linear barcodes and dot matrix 2D barcodes, she adds, because UDIs will use these multiple formats.
The largest materials management IS (MMIS) vendors, Lawson, PeopleSoft, McKesson Pathways, and Meditech, will all support the standards needed to use UDI, says Byer, though not every MMIS does. He’s confident larger hospitals with the available capital will implement the UDI system. But all hospitals need to move in that direction, because the information captured will be so useful in cost and efficiency initiatives.
Many hospitals already use barcode scanning for medications, he notes, because the FDA requires pharmaceuticals to be barcoded.
These are some issues OR leaders may wish to comment on in the proposed UDI rule.
Whose responsibility would it be to track devices and other products in kits? The FDA proposes that each “convenience kit,” such as a surgical pack, would have its own UDI and that each device within the kit would also need a UDI. (Exceptions are devices intended for single use.)
Sargent says in her opinion, the manufacturer, not the hospital, should be responsible for tracking individual items within kits.
“If there is a product in the pack that is recalled, that information should be maintained at the manufacturer level,” she says. “The manufacturer would know what packs that product went into.” Then only customers who received those packs would be notified.
Expecting hospitals to track the individual items in a kit would be burdensome, she says. For ORs, it could lead to costly case delays and cancellations. For example, if nurses have to scan a kit’s contents while setting up for a case, they might find out too late that one of the devices has been recalled, delaying the case.
“That’s why I think the manufacturers need to have that responsibility,” she says. “We don’t want to get into the OR and find out we have a problem.”
Is it worth clinicians’ time to scan noncritical items, such as an arm sling, that carry minimal risk?
“We understand the importance of tracking critical and a lot of semi-critical items,” Sargent says. “But when you get to noncritical items, what’s the risk? Do we really want clinicians spending time scanning these products?”
The FDA proposes to allow multiple agencies to issue UDIs, saying it wants to foster competition. That would include GS1 Healthcare, HIBCC (the Health Industry Business Communications Council), and perhaps others accredited by FDA.
Many hospitals will probably comment that they want a uniform standard, not 2 or 3 different ones, Byer says. ❖
Learn more about the FDA’s UDI plans at www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/UniqueDeviceIdentification/default.htm.